Tasly Pharmaceutical Group Co.,Ltd. Posted 262.7 Million Yuan Net Profit in First Quarter of 2023

Tasly Pharmaceutical Group Co.,Ltd. (天士力医药集团股份有限公司) (600535.SH) reported a net profit of 262.7 million yuan in the first quarter of 2023, reversing a net loss of 595.8 million yuan for the same period in the previous year.

Meanwhile, the company posted 2.1 billion yuan in revenue, up 10.9% year-on-year.

At the end of the reporting period, it had 17.8 billion yuan in total assets and 4.9 billion yuan in total liabilities, with a liability-to-asset ratio of 27.8%.